Our Leadership

Sharon Timberlake

Vice President of Clinical, Quality, and Regulatory Affairs

Sharon started her position as the Vice President of Clinical, Quality, and Regulatory Affairs at Gentuity in 2020. Prior to joining the team, Sharon worked at Syneron-Candela Medical, T2 Biosystems, Inc., and had her own medical device consultancy. She has a proven track record of success with start-up and small medical device companies where she uses her wealth of knowledge to develop clinical and regulatory strategies to support company growth and bring disruptive technology to the global marketplace. She finds inspiration in helping improve people’s lives through breakthrough clinical technology and cultivates a strong team environment by building a roadmap for execution. She was also nominated and elected to the FDA Advisory Panels as an Industry Representative for two different device categories, which was an incredible honor and achievement as it reflects recognition from her peers, industry, and the FDA.

Sharon brings a high level of energy and attention to detail to the team, and her most important goal is to maintain the highest quality product to ensure patient safety. She holds many industry certifications as well as a bachelor’s degree in Business Administration with a concentration in Marketing from Fitchburg State University and a Master’s in Health Sciences, Clinical Leadership from George Washington University.

David W. Kolstad

Chief Executive Officer

Dr. Desmond Adler

President of Cardiovascular

Renny Clark

Chief Financial Officer

John Goodnow

Co-Founder & Executive Vice President R&D, Manufacturing, and Operations

Sharon Timberlake

Vice President of Clinical, Quality, and Regulatory Affairs

Chris Parker

Vice President of Global Market Development

John Kummailil

Vice President of Operations

Susan Burnley

Vice President of Marketing and Business Development